Adult survivors of childhood cancer have a higher risk of heart problems than other adults, but are much less likely to be treated for heart disease risk factors such as high blood pressure, diabetes and high cholesterol, new research shows.
The findings highlight the need for greater awareness among both doctors and patients of the increased risk of heart disease among the estimated 500,...
A blood test could save some colon cancer patients from getting unnecessary chemotherapy following surgery, while making sure that those who would benefit from the treatment get it, researchers report.
The circulating tumor DNA (ctDNA) test looks for minute amounts of genetic material that are released by...
THURSDAY, June 2, 2022 (HealthDay News) -- The United States spends far more on cancer care than other wealthy nations, but it's not seeing a return on that investment in terms of lives saved, a new study shows.
An experimental drug, added to chemotherapy, may benefit women with an aggressive form of breast cancer, suggests an early study offering much-needed good news.
The study involved women with "triple-negative" breast cancer, which accounts for about 15% to 20% of breast cancers among U.S. women. It is so called because the cancers lack receptors for the hormones estrogen and progesterone, ...
Children with the rare cancer neuroblastoma often succumb to the disease despite aggressive treatment. But researchers have found that adding an experimental antibody to that treatment, right off the bat, may improve their outlook.
Of 64 children treated with the antibody in a clinical trial, 74% were still alive and free of a recurrence three years later. That compares with historical ra...
Women with breast cancer are known to have heart problems related to treatment, and now a new study shows their odds of developing an abnormal heart rhythm known as atrial fibrillation (a-fib) may increase in the wake of a breast cancer diagnosis.
Women who develop a-fib within a month of a breast cancer diagnosis are more likely to die from heart- or blood vessel-related problems within ...
Since 1971, when the U.S. government made defeating cancer a goal and put major funding behind it, death rates for many cancers have plummeted, but some are increasing, according to a new American Cancer Society report.
Death rates for all cancers combined have declined since passage of the National Cancer Act of 1971, according to the report. For example, in 2019, deaths from lung c...
High-dose radiation therapy may stall tumor growth in patients with advanced lung cancer who are not fully responding to drug therapies, a preliminary study suggests.
The study involved patients whose lung cancer was considered "oligoprogressive." That means the cancer had spread to other sites in the body, and the patients were having a mixed response to standard systemic treatments -- i...
When Brooklyn-based mom and fashion designer Suzanne Weiner began treatment for breast cancer three years ago, her medical marijuana card was her best friend.
"Pot helped me tremendously with the anxiety and stress of my diagnosis," she said. "I was a mess." Weiner still smokes marijuana regularly to help lessen the side effects of an ongoing treatment that helps keep her cancer at bay.
The cancer drug cisplatin can save children's lives, but often with the side effect of hearing loss. Now a new study shows that young children are especially vulnerable, and the hearing damage may begin early in the course of treatment.
The researchers said the findings highlight the need to screen kids' hearing during each round of cisplatin treatment, to catch problems early.
If you have cancer and you think coronavirus vaccines may do you little good, don't let your hesitation stop you from getting the shots: A pair of clinical trials finds that patients' immune systems ramped up after vaccination.
The findings were presented this week during a virtual meeting of the European Society for Medical Oncology (ESMO Congress 2021).
Immunotherapy helped extend the lives of some patients with the most common type of advanced colon cancer, researchers report.
The new findings are important, they noted, because immunotherapy doesn't typically work against microsatellite stable (MSS) colon cancer. These patients have few treatment options once their disease no longer responds to chemotherapy.
Significant fatigue at the start of cancer treatment is associated with a greater risk of severe side effects and shorter survival, a new study finds.
Researchers analyzed data from four clinical trials of lung cancer or prostate cancer treatments that were conducted by the SWOG Cancer Research Network, a cancer clinical trials group funded by the U.S. National Cancer Institute.
After being diagnosed with bladder cancer, some patients face an almost impossible decision -- have their bladder removed or take a risk knowing that the cancer may be more likely to spread if the bladder is left intact.
But what if there was another way?
For David Cabelis, 68, the decision was more straightforward than most, as he had a unique opportunity to take part in a clinical...
A small but significant percentage of Americans take medications that can hamper their immune system and its response to COVID-19 vaccines, researchers say.
Their analysis of data from more than 3 million adults under 65 with private insurance found that nearly 3% take immunosuppressive drugs. Those include chemotherapy medications and steroids such as prednisone.
Early in the pandemic, some were concerned that breast cancer treatments that weaken the immune system might increase a person's risk of catching or dying from COVID-19.
Now, new research shows that women who have these treatments are no more likely to become sick from the novel coronavirus or to die from it than women being treated with other cancer treatments that do not weaken immune d...
As the COVID-19 pandemic unfolded, breast cancer experts realized space in operating rooms and hospitals could become scarce. That meant rethinking standard care, to provide the best way to treat patients under these suddenly restricted conditions.
One of the new ideas: Reverse the order of care given to patients with a type of breast cancer known as estrogen receptor-positive (ER+). ER+ ...
A cutting-edge experimental drug cuts nearly in half the risk of death among patients with a rare but aggressive cancer of the eye, new clinical trial data show.
Tebentafusp has now become the first drug shown to improve overall survival in patients with uveal melanoma, said Dr. Antoni Ribas, immediate past president of the American Association of Cancer Research (AACR), in a
Angie Gaytan never cared much for beets, but beets sure do love her -- doctors say that veggie shakes, fruits, beet juice and other healthy foods likely helped the 16-year-old defeat her life-threatening leukemia.
Such a healthy diet helped more than Angie: A new study found that adopting a low-fat, low-sugar diet appeared to boost the effectiveness of chemotherapy in a group of 40 childr...
Women with advanced ovarian cancer often face grim statistics, with less than half surviving for five years after their diagnosis. However, a new study suggests that so-called "maintenance therapy" with a targeted cancer drug may add years to some patients' lives.
In findings described by some experts as "remarkable," the study showed that women with advanced ovarian cancer linked to the ...
Stem cell transplants may have long-lasting benefits for some people with aggressive cases of multiple sclerosis, a new study suggests.
Italian researchers found that among 210 multiple sclerosis (MS) patients who received a stem cell transplant -- with cells from their own blood -- two-thirds saw no worsening in their disability 10 years out.
Women with advanced breast cancer who undergo surgery to remove the tumor after chemotherapy or another type of systemic treatment may live longer than those who don't have surgery, a new study suggests.
The findings challenge a long-held belief that surgery confers little benefit for women with stage 4 breast cancer unless the cancer is causing pain, bleeding or other symptoms. Stage 4 i...
More women with early-stage breast cancer may be able to safely skip chemotherapy after having surgery, according to initial results from a major clinical trial.
The trial, conducted in nine countries, found that adding chemotherapy to hormone-blocking drugs brought no added benefit to a particular group of patients. Those were postmenopausal women with hormone-sensitive breast cancer tha...
When a young woman is diagnosed with breast cancer, many questions go through her mind.
What treatments does she need? Will she survive? And will she still be able to have a baby?
In a review of recent research, an international team of investigators say the answer to that critical third question is yes. Though breast cancer survivors are less likely to become pregnant than the ave...
Christina Kosyla, a drama and yoga teacher in her late 20s, was about to take the trip of a lifetime when she felt a strange twinge in her shoulder. A co-worker also pointed out some slight swelling in Kosyla's shoulder.
Kosyla and her best friend were planning to hike the Camino De Santiago -- a 500-mile pilgrimage from France to Spain that required exceptional physical fitness and ...
A combination of chemotherapy and immunotherapy may slow the progress of metastatic bladder cancer and extend survival, a clinical trial suggests.
Current treatment for advanced bladder cancer is chemotherapy, but adding the immunotherapy drug atezolizumab (Tecentriq) appears to help more patients fight this disease. It strikes 81,000 Americans a year and kills 18,000.
Cholesterol-lowering statins are commonly used to help prevent heart disease. Now a new study hints that they could shield women's hearts from the harms of certain breast cancer drugs.
The study focused on women in Canada who'd been treated with either chemotherapy drugs called anthracyclines or the medication Herceptin. Though the treatments can be lifesaving, they can also damage th...
New treatments for melanoma have dramatically reduced deaths from this often fatal skin cancer.
Leaders of a new study report that the death rate from aggressive melanoma that spread to other organs plummeted 18% between 2013 and 2016, after jumping 7.5% between 1986 and 2013. The figures apply to white Americans, the group that accounts for nearly all cases of melanoma in th...
Many people don't realize that cancer patients are in constant need of blood supplies.
Chemotherapy and radiation treatments for cancer can damage the body's ability to produce healthy blood cells and cause potentially life-threatening conditions. Blood transfusions help provide critical clotting factors, proteins and antibodies.
Chemotherapy can be hard on the heart, but an individualized exercise program may mitigate some of that damage, new research suggests.
Heart problems are a common side effect in patients with cancer because cancer treatments can impair heart function and structure or accelerate development of heart disease, especially when patients have risk factors such as high blood pressure, accor...
Early treatment with an immune-boosting therapy might improve the outlook of young children with an advanced form of cancer, a new small study suggests.
The trial involved 43 children with high-risk neuroblastoma, a cancer that starts in immature nerve cells. Researchers found that a new treatment approach -- involving an experimental antibody given right off the bat -- started to qui...
The treatments that childhood cancer patients receive often save their lives, but they also make survivors prone to heart troubles, a new study finds.
For the study, researchers examined heart disease rates in nearly 7,300 childhood cancer survivors (diagnosed at an average age of 7) and a "control group" of more than 36,000 people without cancer in the province of Ontario, Canada.
Could the DNA from a patient's breast tumor help doctors spot whether stray cancer cells are still in her blood?
That's what a small, new study suggests is possible. If the findings are replicated in a larger study, such a test might help determine whether a treatment is working or not. It also has the potential to reduce unnecessary additional treatments for breast cancer.